TABLE 1.
Performance of rapid immunochromatographic test and the reference ELISA with sera from hepatitis E patients, other patient controls, and healthy donors
| Serum group and patient status | No. of serum samples | No. of samples positive by the method of:
|
|
|---|---|---|---|
| Reference ELISA | Rapid test | ||
| Patients with: | |||
| Acute hepatitis E (Nepal 1) | 80 | 79 | 77 |
| Acute hepatitis E (Nepal 2) | 30 | 30 | 30 |
| Acute hepatitis E (China) | 41 | 41 | 39 |
| Total for group | 151 | 150 | 146 |
| Other hepatitis patients: | |||
| HAV antibody positive | 65 | 2 | 0 |
| HBsAg positive | 13 | 1 | 0 |
| HCV antibody positive | 10 | 0 | 0 |
| Total for group | 88 | 3 | 0 |
| Other patient controls: | |||
| HSV IgM positive | 10 | 0 | 0 |
| Toxo IgM Positive | 5 | 0 | 0 |
| Rheumatoid arthritis | 5 | 1 | 1 |
| Systemic lupus | 5 | 0 | 0 |
| Total for group | 25 | 1 | 1 |
| Healthy controls: | |||
| Blood donors (Australia) | 30 | 0 | 0 |
| Healthy individuals (Nepal) | 30 | 1 | 0 |
| Blood donors (United States) | 35 | 0 | 2 |
| Total for group | 95 | 1 | 2 |